Anti-virus and anti-germ nasal cavity device

文档序号:977842 发布日期:2020-11-06 浏览:6次 中文

阅读说明:本技术 防病毒病菌鼻腔器 (Anti-virus and anti-germ nasal cavity device ) 是由 陆学智 于 2020-06-30 设计创作,主要内容包括:本发明公开了一种防病毒病菌鼻腔器,适用于医疗器材领域。其特征在于鼻腔给药方式的重大改变。现有给药方式是用喷雾将药剂喷入鼻腔,防病毒病菌鼻腔器是在使用前将此器浸入对症的药剂或将对症的药剂喷入此器中,使药剂渗入此器,然后取出再将此器塞入鼻腔。此器能阻断鼻腔表面的非特异性蛋白酶(ACE2)表面受体与冠状病毒表面刺突糖蛋白(S蛋白)的吸附结合。使之冠状病毒不能进入细胞,也就不能产生病毒的增殖。鼻腔器内的药剂糖蛋白(针对病毒)诱使病毒表面刺突糖蛋白(S蛋白)吸附,使之病毒表面(S蛋白)遭破坏,即使病毒没有死,也没有再进入细胞的可能性,无法再增殖病毒。(The invention discloses a virus and germ preventing nasal cavity device, which is suitable for the field of medical equipment. It is characterized by a major change in the way nasal administration is made. The existing drug delivery method is to spray the drug into the nasal cavity by spraying, and the anti-virus and anti-germ nasal cavity device is to immerse the device into the corresponding drug or spray the corresponding drug into the device before use, so that the drug permeates into the device, and then the device is taken out and plugged into the nasal cavity. The device can block the adsorption and combination of nonspecific protease (ACE2) surface receptor on nasal cavity surface and coronavirus surface spike glycoprotein (S protein). So that the coronavirus can not enter the cell, and the virus can not be proliferated. The drug glycoprotein (against virus) in the nasal cavity induces the adsorption of virus surface spike glycoprotein (S protein), so that the virus surface (S protein) is damaged, even if the virus is not dead, the possibility of reentering the cell is avoided, and the virus can not be propagated.)

1. An anti-virus and anti-germ nasal cavity device is characterized in that the administration mode of the nasal cavity device is greatly changed. The existing administration mode is to spray the medicine into the nasal cavity by spraying, and the antivirus and germ-resistant nasal cavity device is to dip the device into the symptomatic medicine or spray the symptomatic medicine into the device before use, and then plug the device into the nasal cavity for use.

2. The apparatus according to claim 1, wherein the apparatus is made of medical fine-pored soft silica gel.

3. An anti-viral nasal cavity apparatus according to claim 2 wherein there are 6 layers inside the nasal cavity apparatus, each layer having 6 cylinders of 1mm diameter of the same material.

4. An anti-viral nasal cavity apparatus according to claim 2 wherein the characteristic colour is pink or meat pink.

5. An anti-virus and anti-germ nasal cavity device as claimed in claim 2, wherein the external dimensions of the device are divided into three different sizes, large, medium and small.

Technical Field

The invention relates to the technical field of medical equipment, in particular to a virus and germ preventing nasal cavity device

Background

At present, the nasal cavity antivirus bacteria is administrated in a spray form, and is also one of effective methods. However, the medicine is sprayed into the nose and then the medicine flows out, so that the medicine cannot be kept in the nose for a long time, and the curative effect is poor. The nasal cavity has a non-specific protease (ACE2) on its inner surface, which is a tissue susceptible to virus infection, the direct receptor of virus, and is very susceptible to infection when entering the nasal cavity. At present, medicaments and vaccines for treating coronary pneumonia are carried out in a human body, and can reach a focus through a long route such as stomach, liver, heart, blood and the like, and there is a possibility that the medicaments and vaccines damage organs. Such as killing immune cells, liver tissue damage, etc. Various vaccines are also subjected to long-term clinical tests, and the coronavirus (RNA) single-stranded structure and virus mutation speed also influence the using effect of the vaccines. What needs to be solved at present is the first gateway for keeping virus and germ entering human body: the nasal cavity is inactivated before entering the lungs.

Disclosure of Invention

In order to overcome the defects of the prior art, the invention provides a virus and germ prevention nasal cavity device. It is made of medical fine-hole flexible silica gel material and is put into the nasal cavity for use. The material has been used for nose augmentation, chest augmentation, palate modification and other applications in medical field. Is safe and harmless to human body. The main functions are as follows: firstly, non-specific protease (ACE2) receptor tissues rich in the inner surface of the nasal cavity are blocked, so that virus and germs can not directly infiltrate into cells in the nasal cavity to infect. Secondly, the anti-virus and anti-germ nasal cavity device is made of medical fine-hole flexible silica gel materials, and has large specific surface area, large medicament absorption amount and longer time of staying in the nasal cavity. Medicament glycoprotein (mainly aiming at viruses) on the inner surface and the space of the nasal cavity device for virus and bacteria induces the viruses to adsorb, so that the produced virus surface spike glycoprotein is damaged, and even if the viruses are not dead, the functions of adsorbing and entering cells to proliferate in large quantity are not realized. Fourthly, the contact of various viruses and germs on the nasal cavity surface is blocked, and the chance of infection is reduced. Various symptomatic medicaments are implemented to completely inactivate various viruses and germs at a first gateway of entering a human body. Using the device to strengthen the protection function for medical staff in hospitals and serious epidemic areas. People in occasions such as airplanes, schools, staff dining halls, hotels and restaurants can take off the mask to eat and reduce the chance of being infected through nasal cavities and respiratory tracts. The device can be removed after use, washed by clean water, extruded and dried for reuse. Has both social and economic benefits.

5页详细技术资料下载
上一篇:一种医用注射器针头装配设备
下一篇:一种消化内科催吐装置

网友询问留言

已有0条留言

还没有人留言评论。精彩留言会获得点赞!

精彩留言,会给你点赞!